Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

Metronidazole: newly recognized cause of autonomic neuropathy.

Publication ,  Journal Article
Hobson-Webb, LD; Roach, ES; Donofrio, PD
Published in: J Child Neurol
May 2006

Metronidazole is a commonly used antibiotic prescribed for the treatment of anaerobic and protozoal infections of the gastrointestinal and genitourinary tracts. It is associated with numerous neurologic complications, including peripheral neuropathy. Neuropathy is typically detected in patients on chronic therapy, although it has been documented in those taking large doses for acute infections. Numerous case reports have been published describing motor and sensory neuropathy, yet autonomic neuropathy has not been described with metronidazole use. A previously healthy 15-year-old girl presented with complaints of burning pain in her feet following a short course of metronidazole for vaginitis. She could obtain pain relief only by submerging her feet in ice water. Examination revealed cold and swollen lower extremities that became erythematous and very warm when removed from the ice water. Temperature perception was reduced to the upper third of the shin bilaterally. Deep tendon reflexes and strength were preserved. Nerve conduction studies demonstrated a peripheral neuropathy manifested by reduced sensory nerve and compound muscle action potentials. Reproducible sympathetic skin potential responses could not be obtained in the hand and foot, providing evidence of a concurrent autonomic neuropathy. A thorough evaluation revealed no other cause for her condition. Repeated nerve conduction studies and sympathetic skin potentials returned to normal over the course of 6 months, paralleling the patient's clinical improvement. Metronidazole is a potential cause of reversible autonomic neuropathy.

Duke Scholars

Published In

J Child Neurol

DOI

ISSN

0883-0738

Publication Date

May 2006

Volume

21

Issue

5

Start / End Page

429 / 431

Location

United States

Related Subject Headings

  • Somatosensory Disorders
  • Peroneal Nerve
  • Neurology & Neurosurgery
  • Metronidazole
  • Humans
  • Female
  • Autonomic Nervous System Diseases
  • Anti-Infective Agents
  • Adolescent
  • Action Potentials
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hobson-Webb, L. D., Roach, E. S., & Donofrio, P. D. (2006). Metronidazole: newly recognized cause of autonomic neuropathy. J Child Neurol, 21(5), 429–431. https://doi.org/10.1177/08830738060210051201
Hobson-Webb, Lisa D., E Steve Roach, and Peter D. Donofrio. “Metronidazole: newly recognized cause of autonomic neuropathy.J Child Neurol 21, no. 5 (May 2006): 429–31. https://doi.org/10.1177/08830738060210051201.
Hobson-Webb LD, Roach ES, Donofrio PD. Metronidazole: newly recognized cause of autonomic neuropathy. J Child Neurol. 2006 May;21(5):429–31.
Hobson-Webb, Lisa D., et al. “Metronidazole: newly recognized cause of autonomic neuropathy.J Child Neurol, vol. 21, no. 5, May 2006, pp. 429–31. Pubmed, doi:10.1177/08830738060210051201.
Hobson-Webb LD, Roach ES, Donofrio PD. Metronidazole: newly recognized cause of autonomic neuropathy. J Child Neurol. 2006 May;21(5):429–431.
Journal cover image

Published In

J Child Neurol

DOI

ISSN

0883-0738

Publication Date

May 2006

Volume

21

Issue

5

Start / End Page

429 / 431

Location

United States

Related Subject Headings

  • Somatosensory Disorders
  • Peroneal Nerve
  • Neurology & Neurosurgery
  • Metronidazole
  • Humans
  • Female
  • Autonomic Nervous System Diseases
  • Anti-Infective Agents
  • Adolescent
  • Action Potentials